世界の不妊検査市場(~2025年):製品別(排卵予測キット、不妊治療モニター(尿、唾液、血液))、購入法別(OTC、処方箋、オンライン)、用途別(女性、男性)、エンドユーザー別(在宅医療、不妊治療クリニック、病院)

◆英語タイトル:Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine, Saliva, Blood)), Mode of Purchase (OTC, Prescription, Online), Application (Female, Male), End User (Home care, Fertility clinics, hospitals) - Global Forecast to 2025
◆商品コード:MD4215
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2029年4月15日
◆ページ数:178
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は、世界の不妊検査市場規模が2020年472百万ドルから2025年680百万ドルまで、年平均7.5%成長すると予測しています。本調査レポートでは、不妊検査の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(排卵予測キット、不妊治療モニター、男性用不妊検査製品)分析、購入法別(直接販売/処方薬、OTC、オンライン)分析、用途別(女性用、男性用)分析、エンドユーザー別(在宅医療、病院・不妊治療クリニック、その他)分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の不妊検査市場規模:製品別(排卵予測キット、不妊治療モニター、男性用不妊検査製品)
・世界の不妊検査市場規模:購入法別(直接販売/処方薬、OTC、オンライン)
・世界の不妊検査市場規模:用途別(女性用、男性用)
・世界の不妊検査市場規模:エンドユーザー別(在宅医療、病院・不妊治療クリニック、その他)
・世界の不妊検査市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The fertility test market is projected to reach USD 680 Million by 2025 from USD 472 Million in 2020, at a CAGR of 7.5 % the forecast period.”
Growth in this market is primarily driven by by the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and the increased awareness of fertility testing in both developed as well as developing countries.

“In terms Purchase mode, OTC segment to register significant growth during the forecast period..”
Based on the mode of purchase, the fertility test market is segmented into direct/prescription, OTC, and online products. In 2020 the OTC segment had the major market share and exibited high growth. The high growth of this segment is attributed to the inclination of patients towards self-monitoring of healthcare conditions, increasing initiatives by market players to spread awareness on fertility, and the rising preference for confidentiality and accessibility of test results.

“In terms Application, the female fertility testing segment is expected to account for the largest share of the fertility test market in 2020.”
Based on the application, the fertility test market is segmented into female fertility testing and male fertility testing. In 2020, the female fertility testing segment accounted for a larger market share, primarily due to the decreasing female fertility rates, availability of a wide range of fertility testing options for females, increase in gynecological issues in women (such as PCOD/PCOS), and the high cost of IVF procedures.

“In terms of product segment, ovulation prediction kits segment is expected to account for the largest share during the forecast period.”
Based on products, the fertility test market is segmented into ovulation prediction kits, fertility monitors & male fertility testing products. Large share is attributed to ovulation prediction kits segment due to the increasing use of ovulation prediction kits, easy over-the-counter availability and low cost, and higher accuracy than natural fertility testing techniques, such as calendar methods and cervical mucus monitoring.

“The home care settings segment is expected to register the highest CAGR during the forecast period” `
Based on end-users, the fertility test market has been segmented based on end-user category—home care settings, hospitals and fertility clinics, and other end users. The large share and high growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions, easy access to fertility and ovulation monitors on e-commerce websites, availability of user-friendly and easy-to-handle devices, and the growing preference for the confidentiality of test results.

“Asia Pacific market is expected to grow at the highest CAGR during the forecast period.”
The Asia Pacific market is projected to register the highest CAGR during the forecast period. Growth in the Asia Pacific market is majorly due to the growing number of women suffering from lifestyle disorders, increasing funding/investments toward the development of fertility and ovulation monitors, and the growing focus of both international and domestic players on the Asia Pacific fertility test market.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: C-level–10%, Director-level–14%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%

Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), bioZhena (US), Fairhaven Health (US), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (US), UEBE Medical (Germany), AdvaCare Pharma (US), AVA (Switzerland), Babystart (UK), Valley Electronics (Germany), Sensiia (UK), and Mira Care (US), among others are some of the major players operating in the global fertility test market.

Research Coverage
This report studies the fertility test market based on application, mode of purchase, by products, end user, and region. It studies significant factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It explains micro markets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four major regions and their respective major countries.

Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the fertility test market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the fertility test market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the fertility test market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

【レポートの目次】

1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS AND EXCLUSIONS 25
1.3 MARKET SCOPE 26
1.3.1 MARKETS COVERED 26
1.3.2 YEARS CONSIDERED FOR THE STUDY 26
1.4 CURRENCY USED FOR THE STUDY 27
1.5 STAKEHOLDERS 27
1.6 SUMMARY OF CHANGES 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
FIGURE 1 RESEARCH DESIGN 28
2.1.1 SECONDARY DATA 29
2.1.1.1 Indicative list of secondary sources 30
2.1.2 PRIMARY DATA 31
FIGURE 2 PRIMARY SOURCES 31
FIGURE 3 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION 32
2.2 MARKET ESTIMATION METHODOLOGY 32
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 33
2.2.1 PRODUCT-BASED MARKET ESTIMATION 33
2.2.2 VOLUME-BASED MARKET ESTIMATION 34
FIGURE 5 MARKET SIZE ESTIMATION: FERTILITY TEST MARKET 34
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 35
2.2.3 PRIMARY RESEARCH VALIDATION 35
2.3 DATA TRIANGULATION 36
FIGURE 7 DATA TRIANGULATION METHODOLOGY 36
2.4 RESEARCH ASSUMPTIONS 37
2.5 RESEARCH LIMITATIONS 37
3 EXECUTIVE SUMMARY 38
FIGURE 8 FERTILITY TEST MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 38
FIGURE 9 FERTILITY TEST MARKET, BY MODE OF PURCHASE,
2020 VS. 2025 (USD MILLION) 39
FIGURE 10 FERTILITY TEST MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION) 39
FIGURE 11 FERTILITY TEST MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 40
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE FERTILITY TEST MARKET 41
4 PREMIUM INSIGHTS 42
4.1 FERTILITY TEST MARKET OVERVIEW 42
FIGURE 13 INCREASING FIRST-TIME PREGNANCY AGE TO DRIVE MARKET GROWTH 42
4.2 FERTILITY TEST MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 43
FIGURE 14 OVULATION PREDICTION KITS SEGMENT TO DOMINATE THE MARKET IN 2025 43
4.3 APAC FERTILITY TEST MARKET SHARE, BY COUNTRY AND APPLICATION (2020) 44
FIGURE 15 FEMALE FERTILITY TESTING SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC FERTILITY TEST MARKET IN 2020 44
4.4 FERTILITY TEST MARKET SHARE, BY END USER, 2020 VS. 2025 45
FIGURE 16 HOME CARE SETTINGS ARE THE LARGEST END USERS OF FERTILITY TESTING PRODUCTS 45
4.5 FERTILITY TEST MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 46
FIGURE 17 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
FIGURE 18 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
5.2.1 DRIVERS 48
5.2.1.1 Increasing first-time pregnancy age 48
5.2.1.2 Declining fertility rates across the globe 48
FIGURE 19 DECLINE IN FERTILITY RATE IN THE US, 2008–2018 49
5.2.1.3 Growing population of women of reproductive age 49
5.2.1.4 Launch of advanced, easy-to-use fertility testing devices with high accuracy 49
5.2.1.5 Increasing awareness of fertility testing 50
5.2.1.6 Growing number of gynecological and reproductive issues in women and men 50
5.2.2 RESTRAINTS 51
5.2.2.1 Lesser precision of ovulation prediction kits 51
5.2.2.2 Unproven accuracy of urine-based ovulation monitors in PCOS/
PCOD patients 51
5.2.3 OPPORTUNITIES 52
5.2.3.1 Emergence of combined kits for dual testing of pregnancy and ovulation 52
5.2.3.2 Emerging nations to offer new growth avenues 52
5.2.3.3 Online sales of fertility testing devices 53
5.2.3.4 High cost and low accuracy of IVF treatment 53
TABLE 1 COST OF IVF ACROSS VARIOUS COUNTRIES 53
5.2.4 CHALLENGES 54
5.2.4.1 High cost of fertility testing monitors 54
5.3 ECOSYSTEM COVERAGE: PARENT MARKET (IN VITRO DIAGNOSTICS) 54

5.4 REGULATORY ANALYSIS 55
5.4.1 US 55
TABLE 2 US FDA: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES 55
FIGURE 20 US: REGULATORY PROCESS FOR IVD DEVICES 56
5.4.2 CANADA 57
TABLE 3 CANADA: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES 57
FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 58
5.4.3 EUROPE 58
TABLE 4 EUROPE: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES 59
FIGURE 22 EUROPE: REGULATORY PROCESS FOR IVD DEVICES 60
5.4.4 JAPAN 60
TABLE 5 CLASSIFICATION OF IVD REAGENTS IN JAPAN 61
5.4.5 CHINA 61
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES 61
TABLE 7 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 62
5.4.6 INDIA 62
FIGURE 23 INDIA: REGULATORY PROCESS FOR IVD DEVICES 62
5.5 VALUE CHAIN ANALYSIS 63
5.6 PRICING TREND ANALYSIS 63
TABLE 8 AVERAGE PRICE OF FERTILITY TESTING PRODUCTS, BY COUNTRY, 2020 (USD) 63
5.7 PORTER’S FIVE FORCES ANALYSIS 64
5.7.1 OVERVIEW 64
TABLE 9 FERTILITY TEST MARKET: PORTER’S FIVE FORCES ANALYSIS 64
5.7.2 THREAT OF NEW ENTRANTS 64
FIGURE 24 THREAT OF NEW ENTRANTS 65
5.7.3 THREAT OF SUBSTITUTES 65
FIGURE 25 THREAT OF SUBSTITUTES 65
5.7.4 BARGAINING POWER OF SUPPLIERS 66
FIGURE 26 BARGAINING POWER OF SUPPLIERS 66
5.7.5 BARGAINING POWER OF BUYERS 66
FIGURE 27 BARGAINING POWER OF BUYERS 67
5.7.6 DEGREE OF COMPETITION 67
FIGURE 28 DEGREE OF COMPETITION 67
5.8 NUMBER OF PATIENTS UTILIZING SPECIFIC FERTILITY TECHNIQUES WORLDWIDE
(AS OF 2019) 68
TABLE 10 NUMBER OF PATIENTS UTILIZING SPECIFIC FERTILITY TECHNIQUES WORLDWIDE (AS OF 2019) 68
5.9 COVID-19 IMPACT 68
6 FERTILITY TEST MARKET, BY PRODUCT 69
6.1 INTRODUCTION 70
TABLE 11 FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 70

6.2 OVULATION PREDICTION KITS 70
6.2.1 LOW COST AND EASY AVAILABILITY OF OVULATION PREDICTION KITS TO DRIVE THEIR ADOPTION 70
TABLE 12 OVULATION PREDICTION KITS MARKET, BY REGION,
2018–2025 (USD MILLION) 71
TABLE 13 OVULATION PREDICTION KITS MARKET, BY MODE OF PURCHASE,
2018–2025 (USD MILLION) 71
TABLE 14 OVULATION PREDICTION KITS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 71
TABLE 15 OVULATION PREDICTION KITS MARKET, BY END USER,
2018–2025 (USD MILLION) 72
6.3 FERTILITY MONITORS 72
TABLE 16 FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION) 73
TABLE 17 FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION) 73
TABLE 18 FERTILITY MONITORS MARKET, BY MODE OF PURCHASE,
2018–2025 (USD MILLION) 73
TABLE 19 FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 74
TABLE 20 FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION) 74
6.3.1 URINE-BASED FERTILITY MONITORS 74
6.3.1.1 Lower user-interpretation errors and fast and accurate results are advantages offered by urine-based monitors 74
TABLE 21 URINE-BASED FERTILITY MONITORS MARKET, BY REGION,
2018–2025 (USD MILLION) 75
TABLE 22 URINE-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION) 75
TABLE 23 URINE-BASED FERTILITY MONITORS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 75
TABLE 24 URINE-BASED FERTILITY MONITORS MARKET, BY END USER,
2018–2025 (USD MILLION) 76
6.3.2 SALIVA-BASED FERTILITY MONITORS 76
6.3.2.1 Saliva-based monitors offer cost-effectiveness and better hygiene 76
TABLE 25 SALIVA-BASED FERTILITY MONITORS MARKET, BY REGION,
2018–2025 (USD MILLION) 76
TABLE 26 SALIVA-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION) 77
TABLE 27 SALIVA-BASED FERTILITY MONITORS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 77
TABLE 28 SALIVA-BASED FERTILITY MONITORS MARKET, BY END USER,
2018–2025 (USD MILLION) 77
6.3.3 BLOOD-BASED FERTILITY MONITORS 77
6.3.3.1 Cost-effectiveness of blood-based monitors is expected to drive their adoption 77
TABLE 29 BLOOD-BASED FERTILITY MONITORS MARKET, BY REGION,
2018–2025 (USD MILLION) 78
TABLE 30 BLOOD-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION) 78
TABLE 31 BLOOD-BASED FERTILITY MONITORS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 78
TABLE 32 BLOOD-BASED FERTILITY MONITORS MARKET, BY END USER,
2018–2025 (USD MILLION) 79
6.3.4 OTHER FERTILITY MONITORS 79
TABLE 33 OTHER FERTILITY MONITORS MARKET, BY REGION,
2018–2025 (USD MILLION) 80
TABLE 34 OTHER FERTILITY MONITORS MARKET, BY MODE OF PURCHASE,
2018–2025 (USD MILLION) 80
TABLE 35 OTHER FERTILITY MONITORS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 80
TABLE 36 OTHER FERTILITY MONITORS MARKET, BY END USER,
2018–2025 (USD MILLION) 81
6.4 MALE FERTILITY TESTING PRODUCTS 81
6.4.1 MALE FERTILITY TESTING PRODUCTS TO ACCOUNT FOR THE LOWEST SHARE OF THE MARKET 81
TABLE 37 MALE FERTILITY TESTING PRODUCTS MARKET, BY REGION,
2018–2025 (USD MILLION) 82
TABLE 38 MALE FERTILITY TESTING PRODUCTS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION) 82
TABLE 39 MALE FERTILITY TESTING PRODUCTS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 82
TABLE 40 MALE FERTILITY TESTING PRODUCTS MARKET, BY END USER,
2018–2025 (USD MILLION) 83
7 FERTILITY TEST MARKET, BY MODE OF PURCHASE 84
7.1 INTRODUCTION 85
TABLE 41 FERTILITY TEST MARKET, BY MODE OF PURCHASE,
2018–2025 (USD MILLION) 85
7.2 DIRECT/PRESCRIPTION PRODUCTS 85
7.2.1 AVAILABILITY OF INSURANCE COVERAGE FOR PRESCRIPTION REFILLS WILL DRIVE THE GROWTH OF THIS SEGMENT 85
TABLE 42 DIRECT/PRESCRIPTION PRODUCTS MARKET, BY REGION,
2018–2025 (USD MILLION) 86
7.3 OTC PRODUCTS 86
7.3.1 TREND OF SELF-MONITORING AND REMOTE ACCESS WILL BOOST THE GROWTH OF THIS SEGMENT 86
TABLE 43 OTC PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION) 87
7.4 ONLINE PRODUCTS 87
7.4.1 INCREASING NUMBER OF E-PHARMACY PLATFORMS BOOSTING THE GROWTH OF THIS SEGMENT 87
TABLE 44 ONLINE PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION) 88
8 FERTILITY TEST MARKET, BY APPLICATION 89
8.1 INTRODUCTION 90
TABLE 45 FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 90
8.2 FEMALE FERTILITY TESTING 90
8.2.1 RISING PREVALENCE OF PCOD/PCOS WILL BOOST THE GROWTH OF THIS SEGMENT 90
TABLE 46 GLOBAL BURDEN OF PCOS, 2019 (PER MILLION) 91
TABLE 47 FERTILITY TEST MARKET FOR FEMALE FERTILITY TESTING APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 92
8.3 MALE FERTILITY TESTING 92
8.3.1 GROWING ADOPTION OF ADVANCED FERTILITY DEVICES TO AID THE GROWTH OF THIS SEGMENT 92
TABLE 48 FERTILITY TEST MARKET FOR MALE FERTILITY TESTING APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 93
9 FERTILITY TEST MARKET, BY END USER 94
9.1 INTRODUCTION 95
TABLE 49 FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION) 95
9.2 HOME CARE SETTINGS 95
9.2.1 EASY ACCESS TO FERTILITY TESTING PRODUCTS THROUGH E-COMMERCE WEBSITES WILL STIMULATE THE GROWTH OF THIS SEGMENT 95
TABLE 50 FERTILITY TEST MARKET FOR HOME CARE SETTINGS, BY REGION,
2018–2025 (USD MILLION) 96
9.3 HOSPITALS AND FERTILITY CENTERS 96
9.3.1 INCREASING NUMBER OF FERTILITY CENTERS TO BOOST THE GROWTH OF THIS SEGMENT 96
TABLE 51 FERTILITY TEST MARKET FOR HOSPITALS AND FERTILITY CENTERS,
BY REGION, 2018–2025 (USD MILLION) 97
9.4 OTHER END USERS 97
TABLE 52 FERTILITY TEST MARKET FOR OTHER END USERS, BY REGION,
2018–2025 (USD MILLION) 97
10 FERTILITY TEST MARKET, BY REGION 98
10.1 INTRODUCTION 99
TABLE 53 FERTILITY TEST MARKET, BY REGION, 2018–2025 (USD MILLION) 99
10.2 NORTH AMERICA 99
FIGURE 29 NORTH AMERICA: FERTILITY TEST MARKET SNAPSHOT 100
TABLE 54 NORTH AMERICA: FERTILITY TEST MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 100
TABLE 55 NORTH AMERICA: FERTILITY TEST MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 101
TABLE 56 NORTH AMERICA: FERTILITY MONITORS MARKET, BY TYPE,
2018–2025 (USD MILLION) 101
TABLE 57 NORTH AMERICA: FERTILITY TEST MARKET, BY MODE OF PURCHASE,
2018–2025 (USD MILLION) 101
TABLE 58 NORTH AMERICA: FERTILITY TEST MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 102
TABLE 59 NORTH AMERICA: FERTILITY TEST MARKET, BY END USER,
2018–2025 (USD MILLION) 102
10.2.1 US 102
10.2.1.1 High incidence of PCOD/PCOS will boost the growth of this market 102
TABLE 60 US: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 103
TABLE 61 US: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION) 103
10.2.2 CANADA 104
10.2.2.1 Decreasing fertility rate and the increasing mean age of first-time pregnancies driving the market 104
TABLE 62 CANADA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 105
TABLE 63 CANADA: FERTILITY MONITORS MARKET, BY TYPE,
2018–2025 (USD MILLION) 105
10.3 EUROPE 105
TABLE 64 EUROPE: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 106
TABLE 65 EUROPE: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 106
TABLE 66 EUROPE: FERTILITY MONITORS MARKET, BY TYPE,
2018–2025 (USD MILLION) 107
TABLE 67 EUROPE: FERTILITY TEST MARKET, BY MODE OF PURCHASE,
2018–2025 (USD MILLION) 107
TABLE 68 EUROPE: FERTILITY TEST MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 107
TABLE 69 EUROPE: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION) 108
10.3.1 GERMANY 108
10.3.1.1 Increasing fertility concerns and awareness to drive market growth in Germany 108
TABLE 70 GERMANY: FERTILITY TEST MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 109
TABLE 71 GERMANY: FERTILITY MONITORS MARKET, BY TYPE,
2018–2025 (USD MILLION) 109
10.3.2 UK 109
10.3.2.1 Government initiatives and promotion of lab-based testing will stimulate market growth 109
TABLE 72 UK: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 110
TABLE 73 UK: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION) 110
10.3.3 FRANCE 110
10.3.3.1 Increasing reforms for the management of POC tests to drive market growth in France 110
TABLE 74 FRANCE: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 111
TABLE 75 FRANCE: FERTILITY MONITORS MARKET, BY TYPE,
2018–2025 (USD MILLION) 111
10.3.4 ITALY 112
10.3.4.1 Decreasing fertility rates to drive the adoption of fertility testing devices in Italy 112
TABLE 76 ITALY: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 112
TABLE 77 ITALY: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION) 112
10.3.5 SPAIN 113
10.3.5.1 Growing awareness of fertility testing products among women to drive market growth 113
TABLE 78 SPAIN: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 113
TABLE 79 SPAIN: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION) 113

10.3.6 REST OF EUROPE 114
TABLE 80 ROE: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 114
TABLE 81 ROE: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION) 115
10.4 ASIA PACIFIC 115
FIGURE 30 ASIA PACIFIC: FERTILITY TEST MARKET SNAPSHOT 116
TABLE 82 ASIA PACIFIC: FERTILITY TEST MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 116
TABLE 83 ASIA PACIFIC: FERTILITY TEST MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 117
TABLE 84 ASIA PACIFIC: FERTILITY MONITORS MARKET, BY TYPE,
2018–2025 (USD MILLION) 117
TABLE 85 ASIA PACIFIC: FERTILITY TEST MARKET, BY MODE OF PURCHASE,
2018–2025 (USD MILLION) 118
TABLE 86 ASIA PACIFIC: FERTILITY TEST MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 118
TABLE 87 ASIA PACIFIC: FERTILITY TEST MARKET, BY END USER,
2018–2025 (USD MILLION) 118
10.4.1 JAPAN 119
10.4.1.1 Increasing average age of first-time pregnancies to drive market growth 119
TABLE 88 JAPAN: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 119
TABLE 89 JAPAN: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION) 120
10.4.2 CHINA 120
10.4.2.1 China dominated the Asia Pacific fertility test market in 2020 120
TABLE 90 CHINA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 121
TABLE 91 CHINA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION) 121
10.4.3 INDIA 121
10.4.3.1 Increasing prevalence of PCOD/PCOS to drive market growth in India 121
TABLE 92 INDIA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 122
TABLE 93 INDIA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION) 122
10.4.4 AUSTRALIA 123
10.4.4.1 Supportive government initiatives and rising investments to drive market growth 123
TABLE 94 AUSTRALIA: FERTILITY TEST MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 123
TABLE 95 AUSTRALIA: FERTILITY MONITORS MARKET, BY TYPE,
2018–2025 (USD MILLION) 123
10.4.5 SOUTH KOREA 124
10.4.5.1 Supportive government initiatives expected to positively impact market growth 124
TABLE 96 SOUTH KOREA: FERTILITY TEST MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 124
TABLE 97 SOUTH KOREA: FERTILITY MONITORS MARKET, BY TYPE,
2018–2025 (USD MILLION) 124
10.4.6 REST OF ASIA PACIFIC 125
TABLE 98 ROAPAC: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 125
TABLE 99 ROAPAC: FERTILITY MONITORS MARKET, BY TYPE,
2018–2025 (USD MILLION) 125
10.5 LATIN AMERICA 125
TABLE 100 LATAM: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 126
TABLE 101 LATAM: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 126
TABLE 102 LATAM: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION) 126
TABLE 103 LATAM: FERTILITY TEST MARKET, BY MODE OF PURCHASE,
2018–2025 (USD MILLION) 127
TABLE 104 LATAM: FERTILITY TEST MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 127
TABLE 105 LATAM: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION) 127
10.5.1 BRAZIL 128
10.5.1.1 Shrinking population concerns will drive market growth 128
TABLE 106 BRAZIL: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 128
TABLE 107 BRAZIL: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION) 128
10.5.2 MEXICO 129
10.5.2.1 Increasing population to drive market growth in Mexico 129
TABLE 108 MEXICO: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 129
TABLE 109 MEXICO: FERTILITY MONITORS MARKET, BY TYPE,
2018–2025 (USD MILLION) 129
10.5.3 REST OF LATIN AMERICA 130
TABLE 110 ROLATAM: FERTILITY TEST MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 130
TABLE 111 ROLATAM: FERTILITY MONITORS MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
10.6 MIDDLE EAST & AFRICA 131
10.6.1 UNFAVORABLE REIMBURSEMENT POLICIES ARE EXPECTED TO RESTRAIN MARKET GROWTH IN MEA 131
TABLE 112 MEA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 131
TABLE 113 MEA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION) 132
TABLE 114 MEA: FERTILITY TEST MARKET, BY MODE OF PURCHASE,
2018–2025 (USD MILLION) 132
TABLE 115 MEA: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 132
TABLE 116 MEA: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION) 133
11 COMPETITIVE LANDSCAPE 134
11.1 OVERVIEW 134
11.2 KEY STRATEGIES 134
11.3 GLOBAL MARKET SHARE ANALYSIS (2019) 135
TABLE 117 FERTILITY TEST MARKET: DEGREE OF COMPETITION 135
FIGURE 31 SWISS PRECISION DIAGNOSTICS HELD THE LEADING POSITION IN THE FERTILITY TEST MARKET IN 2020 135
11.4 COMPETITIVE LEADERSHIP MAPPING 136

11.5 VENDOR INCLUSION CRITERIA 137
11.5.1 STARS 137
11.5.2 EMERGING LEADERS 137
11.5.3 PERVASIVE PLAYERS 137
11.5.4 PARTICIPANTS 137
FIGURE 32 FERTILITY TEST MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019 138
11.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/
START-UPS (2019) 139
11.6.1 PROGRESSIVE COMPANIES 139
11.6.2 STARTING BLOCKS 139
11.6.3 RESPONSIVE COMPANIES 139
11.6.4 DYNAMIC COMPANIES 139
FIGURE 33 FERTILITY TEST MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING,
2019 (SME/START-UPS) 140
11.7 COMPANY PRODUCT FOOTPRINT ANALYSIS 141
TABLE 118 PRODUCT FOOTPRINT OF COMPANIES 141
TABLE 119 APPLICATION FOOTPRINT OF COMPANIES 142
TABLE 120 REGIONAL FOOTPRINT OF COMPANIES 143
11.8 COMPETITIVE SCENARIO 144
11.8.1 PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS 144
TABLE 121 FERTILITY TEST MARKET: PRODUCT LAUNCHES, ENHANCEMENTS,
AND APPROVALS, 2017–2020 144
11.8.2 EXPANSIONS 145
TABLE 122 FERTILITY TEST MARKET: EXPANSIONS, 2017–2020 145
11.8.3 OTHER STRATEGIES 145
TABLE 123 FERTILITY TEST MARKET: OTHER STRATEGIES, 2017–2020 145
12 COMPANY PROFILES 146
12.1 KEY PLAYERS 146
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)*
12.1.1 SWISS PRECISION DIAGNOSTICS 146
TABLE 124 SWISS PRECISION DIAGNOSTICS: BUSINESS OVERVIEW 146
TABLE 125 SWISS PRECISION DIAGNOSTICS: PRODUCTS OFFERED 147
TABLE 126 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2017 TO DECEMBER 2020 147
12.1.2 CHURCH & DWIGHT 149
TABLE 127 CHURCH & DWIGHT: BUSINESS OVERVIEW 149
FIGURE 34 CHURCH & DWIGHT: COMPANY SNAPSHOT (2020) 150
TABLE 128 CHURCH & DWIGHT: PRODUCTS OFFERED 150
12.1.3 PRESTIGE BRANDS HOLDINGS 152
TABLE 129 PRESTIGE BRANDS HOLDINGS: BUSINESS OVERVIEW 152
TABLE 130 PRESTIGE BRANDS HOLDINGS: PRODUCTS OFFERED 152
TABLE 131 FERTILITY TESTS MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020 153
12.1.4 BIOZHENA 154
TABLE 132 BIOZHENA: BUSINESS OVERVIEW 154
TABLE 133 BIOZHENA: PRODUCTS OFFERED 154
12.1.5 FAIRHAVEN HEALTH 155
TABLE 134 FAIRHAVEN HEALTH: BUSINESS OVERVIEW 155
TABLE 135 FAIRHAVEN HEALTH: PRODUCTS OFFERED 155
12.1.6 FERTILITY FOCUS 157
TABLE 136 FERTILITY FOCUS: BUSINESS OVERVIEW 157
TABLE 137 FERTILITY FOCUS: PRODUCTS OFFERED 157
TABLE 138 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2016 TO DECEMBER 2020 158
TABLE 139 FERTILITY TEST MARKET: DEALS, JANUARY 2016 TO DECEMBER 2020 158
12.1.7 GERATHERM MEDICAL 159
TABLE 140 GERATHERM MEDICAL: BUSINESS OVERVIEW 159
FIGURE 35 GERATHERM MEDICAL: COMPANY SNAPSHOT (2019) 159
TABLE 141 EXCHANGE RATES: EUR TO USD 160
TABLE 142 GERATHERM MEDICAL: PRODUCTS OFFERED 160
12.1.8 HILIN LIFE PRODUCTS 161
TABLE 143 HILIN LIFE PRODUCTS: BUSINESS OVERVIEW 161
TABLE 144 HILIN LIFE PRODUCTS: PRODUCTS OFFERED 161
12.1.9 UEBE MEDICAL 162
TABLE 145 UEBE MEDICAL: BUSINESS OVERVIEW 162
TABLE 146 UEBE MEDICAL: PRODUCTS OFFERED 162
12.1.10 ADVACARE PHARMA 163
TABLE 147 ADVACARE PHARMA: BUSINESS OVERVIEW 163
TABLE 148 ADVACARE PHARMA: PRODUCTS OFFERED 163
12.1.11 AVA 164
TABLE 149 AVA: BUSINESS OVERVIEW 164
TABLE 150 AVA: PRODUCTS OFFERED 164
TABLE 151 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2017 TO DECEMBER 2020 165
TABLE 152 FERTILITY TEST MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020 165
12.1.12 BABYSTART (SNOWDEN HEALTHCARE) 166
TABLE 153 BABYSTART: BUSINESS OVERVIEW 166
TABLE 154 BABYSTART: PRODUCTS OFFERED 166
12.1.13 VALLEY ELECTRONICS 167
TABLE 155 VALLEY ELECTRONICS: BUSINESS OVERVIEW 167
TABLE 156 VALLEY ELECTRONICS: PRODUCTS OFFERED 167
12.1.14 SENSIIA 168
TABLE 157 SENSIIA: BUSINESS OVERVIEW 168
TABLE 158 SENSIIA: PRODUCTS OFFERED 168
TABLE 159 FERTILITY TEST MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020 169
12.1.15 MIRA CARE 170
TABLE 160 MIRA CARE: BUSINESS OVERVIEW 170
TABLE 161 MIRA CARE: PRODUCTS OFFERED 170
*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
12.2 OTHER COMPANIES 171
12.2.1 EXSEED HEALTH 171
12.2.2 TEMPDROP 171
12.2.3 PREGMATE 172
12.2.4 MEDICAL ELECTRONIC SYSTEMS 172
12.2.5 SWIM COUNT (SUBSIDIARY OF MOTILTYCOUNT APS) 173
13 APPENDIX 174
13.1 DISCUSSION GUIDE 174
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 180
13.3 AVAILABLE CUSTOMIZATIONS 182
13.4 RELATED REPORTS 182
13.5 AUTHOR DETAILS 183



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の不妊検査市場(~2025年):製品別(排卵予測キット、不妊治療モニター(尿、唾液、血液))、購入法別(OTC、処方箋、オンライン)、用途別(女性、男性)、エンドユーザー別(在宅医療、不妊治療クリニック、病院)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆